Immunogenicity Assay Development, Validation & Transfer in a Vaccine Candidate Clinical Trial

A large global pharmaceutical company, with a promising new vaccine candidate, partnered with Viracor Eurofins to perform immunogenicity testing as part of their clinical trial development. Several specific areas of expertise were called upon to enable the Viracor team to deliver multiple precise, robust and sensitive assays to meet the sponsor's needs.